Back to results
US 2023/0272415 A1Published application
Genetic modification of cytokine inducible sh2-containing protein (cish) gene
AssigneeSangamo Therapeutics, Inc.
InventorsAnthony Conway, Gary K. Lee
Life of this patent
Estimating the term…
Abstract
The present disclosure is in the field of genome engineering, particularly targeted genetic modification of a CISH gene.
Claims13
-10. (canceled)
A zinc finger protein comprising 6 zinc finger domains each comprising a recognition helix region, wherein the zinc finger protein comprises the recognition helix regions of the proteins designated F1-F6 in the order F1 to F6, and wherein the recognition helix region comprises the proteins:
- F1 (SEQ ID NO:
- 2), F2 (SEQ ID NO:
- 3), F3 (SEQ ID NO:
- 4), F4 (SEQ ID NO:
- 5), F5 (SEQ ID NO:
- 6), and F6 (SEQ ID NO:
- 7);
- F1 (SEQ ID NO:
- 8), F2 (SEQ ID NO:
- 9), F3 (SEQ ID NO:
- 10), F4 (SEQ ID NO:
- 11), F5 (SEQ ID NO:
- 9), and F6 (SEQ ID NO:
- 12);
- F1 (SEQ ID NO:
- 13), F2 (SEQ ID NO:
- 14), F3 (SEQ ID NO:
- 10), F4 (SEQ ID NO:
- 15), F5 (SEQ ID NO:
- 16), and F6 (SEQ ID NO:
- 17);
- F1 (SEQ ID NO:
- 18), F2 (SEQ ID NO:
- 19), F3 (SEQ ID NO:
- 20), F4 (SEQ ID NO:
- 21), F5 (SEQ ID NO:
- 18), and F6 (SEQ ID NO:
- 22);
- F1 (SEQ ID NO:
- 23), F2 (SEQ ID NO:
- 24), F3 (SEQ ID NO:
- 25), F4 (SEQ ID NO:
- 26), F5 (SEQ ID NO:
- 27), and F6 (SEQ ID NO:
- 28);
- F1 (SEQ ID NO:
- 29), F2 (SEQ ID NO:
- 30), F3 (SEQ ID NO:
- 16), F4 (SEQ ID NO:
- 31), F5 (SEQ ID NO:
- 32), and F6 (SEQ ID NO:
- 33);
- F1 (SEQ ID NO:
- 34), F2 (SEQ ID NO:
- 35), F3 (SEQ ID NO:
- 32), F4 (SEQ ID NO:
- 36), F5 (SEQ ID NO:
- 37), and F6 (SEQ ID NO:
- 38);
- or
- F1 (SEQ ID NO:
- 27), F2 (SEQ ID NO:
- 28), F3 (SEQ ID NO:
- 25), F4 (SEQ ID NO:
- 39), F5 (SEQ ID NO:
- 32), and F6 (SEQ ID NO:
- 12).
54 more elements
-19. (canceled)
A method of integrating a donor polynucleotide into an endogenous CISH gene comprising:
- (a) contacting one or more cells with a zinc finger nuclease to cleave the endogenous CISH gene, wherein the zinc finger nuclease comprises six zinc finger domains, wherein each zinc finger domain comprises a recognition helix region designated F1-F6 in the order F1 to F6, and wherein the recognition helix region comprises the proteins:
- F1 (SEQ ID NO:
- 2), F2 (SEQ ID NO:
- 3), F3 (SEQ ID NO:
- 4), F4 (SEQ ID NO:
- 5), F5 (SEQ ID NO:
- 6), and F6 (SEQ ID NO:
- 7);
- F1 (SEQ ID NO:
- 8), F2 (SEQ ID NO:
- 9), F3 (SEQ ID NO:
- 10), F4 (SEQ ID NO:
- 11), F5 (SEQ ID NO:
- 9), and F6 (SEQ ID NO:
- 12);
- F1 (SEQ ID NO:
- 13), F2 (SEQ ID NO:
- 14), F3 (SEQ ID NO:
- 10), F4 (SEQ ID NO:
- 15), F5 (SEQ ID NO:
- 16), and F6 (SEQ ID NO:
- 17);
- F1 (SEQ ID NO:
- 18), F2 (SEQ ID NO:
- 19), F3 (SEQ ID NO:
- 20), F4 (SEQ ID NO:
- 21), F5 (SEQ ID NO:
- 18), and F6 (SEQ ID NO:
- 22);
- F1 (SEQ ID NO:
- 23), F2 (SEQ ID NO:
- 24), F3 (SEQ ID NO:
- 25), F4 (SEQ ID NO:
- 26), F5 (SEQ ID NO:
- 27), and F6 (SEQ ID NO:
- 28);
- F1 (SEQ ID NO:
- 29), F2 (SEQ ID NO:
- 30), F3 (SEQ ID NO:
- 16), F4 (SEQ ID NO:
- 31), F5 (SEQ ID NO:
- 32), and F6 (SEQ ID NO:
- 33);
- F1 (SEQ ID NO:
- 34), F2 (SEQ ID NO:
- 35), F3 (SEQ ID NO:
- 32), F4 (SEQ ID NO:
- 36), F5 (SEQ ID NO:
- 37), and F6 (SEQ ID NO:
- 38);
- or
- F1 (SEQ ID NO:
- 27), F2 (SEQ ID NO:
- 28), F3 (SEQ ID NO:
- 25), F4 (SEQ ID NO:
- 39), F5 (SEQ ID NO:
- 32), and F6 (SEQ ID NO:
- 12);
- and
- (b) introducing a donor polynucleotide into the one or more cells, such that the donor polynucleotide is integrated into the cleaved endogenous CISH gene.
57 more elements
Dependencies are inferred from the claim text.